| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.nglfinechem.com | |
| Market Cap | 727.62 Cr. | |
| Enterprise Value(EV) | 742.13 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 30.01 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 39.22 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 32.00 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 345.31 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 3.41 | Calculated using Price: 1,177.00 |
| Dividend Yield | 0.15 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.62 Cr. | 6,178,024 Shares |
| FaceValue | 5 | |
| Company Profile | ||
| NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility. | ||
| 1 Day |
|
-3.22% |
| 1 Week |
|
-5.77% |
| 1 Month |
|
-8.74% |
| 3 Month |
|
-24.55% |
| 6 Month |
|
-19.97% |
| 1 Year |
|
-35.47% |
| 2 Year |
|
-27.56% |
| 5 Year |
|
+186.65% |
| 10 Year |
|
+7577.76% |
| 4 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 21.85 | 8.72 | 44.76 | 27.90 | |
| Return on Capital Employed (%) | 25.25 | 11.93 | 53.53 | 33.91 | |
| Return on Assets (%) | 13.49 | 5.50 | 31.42 | 20.61 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 92 | 99 | 154 | 203 | 207 | |
| Non Curr. Liab. | 12 | 12 | 11 | 8 | 6 | |
| Curr. Liab. | 45 | 43 | 42 | 66 | 61 | |
| Minority Int. | ||||||
| Equity & Liab. | 149 | 154 | 207 | 277 | 274 | |
| Non Curr. Assets | 63 | 73 | 83 | 103 | 114 | |
| Curr. Assets | 86 | 81 | 125 | 173 | 160 | |
| Misc. Exp. not W/O | ||||||
| Total Assets | 149 | 154 | 207 | 277 | 274 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 153 | 152 | 258 | 318 | 288 | |
| Other Income | 4 | 3 | 8 | 11 | 7 | |
| Total Income | 157 | 155 | 266 | 328 | 296 | |
| Total Expenditure | -121 | -132 | -178 | -249 | -257 | |
| PBIDT | 36 | 23 | 88 | 79 | 38 | |
| Interest | -3 | -3 | -2 | -2 | -2 | |
| Depreciation | -6 | -8 | -8 | -10 | -12 | |
| Taxation | -7 | -4 | -21 | -17 | -6 | |
| Exceptional Items | ||||||
| PAT | 20 | 8 | 57 | 50 | 19 | |
| Minority Interest | ||||||
| Share Associate | ||||||
| Other Related Items | 0 | 0 | 0 | |||
| Consolidated Net Profit | 20 | 8 | 57 | 50 | 19 | |
| Adjusted EPS | 33 | 13 | 92 | 81 | 30 |
| Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 9 | 20 | 27 | 14 | |
| Cash Fr. Inv. | -10 | -20 | -25 | -14 | |
| Cash Fr. Finan. | -1 | -1 | -1 | ||
| Net Change | -1 | 0 | 2 | -1 | |
| Cash & Cash Eqvt | 1 | 0 | 2 | 1 |
|
Wed, 22 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sunita Potdar |
|
Thu, 16 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate In compliance with the provisions of Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 and in terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR / 2022 / 8 dated January 25 2022 it is informed that Letter of Confirmation is issued to the following shareholder in lieu of share certificate reported lost by them as details below:Name of the Shareholder KOMAL A SHAHFolio No. K00322Certificate No. 0062273Distinctive No. 2594601-2595100No. of Shares 500Kindly take the same on your record. |
|
Wed, 01 Mar 2023
Re-Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2022 In Machine Readable Form. With reference to the e-mail received from National Stock Exchange of India Limited regarding submission of Unaudited Financial Results in Machine Readable Form / Legible copy we hereby re-submit Unaudited Financial Results along with Limited Review Report for the quarter and nine months ended December 31 2022 in Machine Readable Form. Kindly note that there has been no change in the Un-Audited Financial Results of the Company which was submitted on February 10 2023. Kindly take the same on your record. |
| Tue, 28 Mar 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Equities
M.F.
Sectors